. Author manuscript; available in PMC: 2011 Mar 28.

Published in final edited form as: Anal Chem. 2007 Mar 31;79(10):3830–3842. doi: 10.1021/ac062383a

Table 4. MSⁿ Pathways Topologies for the Ion m/z 1141.6 (Hex₅HexNAc₄deoxyhexose₁) from a Humanized IgG Sample.

Putative Structures

MSⁿ pathways			Consistent topologies
1141.6 1796.8 (loss of ) 1333.6 (loss of )			A,B,C
1141.6 1796.8 (loss of ) 1329.6 (loss of )			A,B,C,D
1141.6 1796.8 (loss of ) 866.4 (loss of and )			A,B,C,D
1141.6 1796.8 (loss of ) 709.4 (Hex-Hex-Hex-HexNAc(cross-ring),^3,5A/Y/Y)			A,B,C
1141.6 1796.8 (loss of ) 662.4 (loss of , , and )			A,B,C,D
1141.6 1792.8 (loss of )			A,B,C,D
1141.6 490.3 (, Y)			A,B,C,D
1141.6 486.3 (, B₂)			A,B,C,D
1141.6 1012.0 (loss of ) 1537.6 (loss of ) 1333.6 (loss of )			B,C
1141.6 1012.0 (loss of ) 1537.6 (loss of ) 852.6 (loss of and )			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 913.4 (^3,5A/Y/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 866.5 (loss of )			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 852.3 (loss of )			C only
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 843.1 (loss of , C/Y/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 825.5 (loss of . B/Y/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 709.6 (loss of , ^3,5A/Y/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 662.4 (loss of , B/Y/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 621.3 (loss of and , B/Y/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 491.3 (Hex-Hex-Hex(cross-ring),^0,4A/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 458.5 (, B/Y/Y)			B only
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 449.6 (, C/Y)			B,C
1141.6 1012.0 (loss of ) 1537.7 (loss of ) 1070.5 (loss of ) 431.4 (, B/Y)			B,C
1141.6 1012.0 (loss of ) 1537.6 (loss of ) 866.4 (loss of and )			B,C
1141.6 1012.0 (loss of ) 1537.6 (loss of ) 490.3 (, Y)			B,C
1141.6 1012.0 (loss of ) 1533.7 (loss of )			B,C,D
1141.6 1012.0 (loss of ) 486.3 (, B₂)			B,C
1141.6 1012.0 (loss of ) 490.3 (, Y)			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 1129.4 (loss of )			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 866.4 (loss of )			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 709.6 (Hex-Hex-Hex-HexNAc(cross-ring),^3,5A/Y/Y)			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 662.5 (loss of and )			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 621.5 (, B/Y/Y)			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 490.1 (, Y)			B,C,D
1141.6 1012.0 (loss of ) 1333.5 (loss of , or equiv.) 458.0 (, B/Y/Y)			B,D
1141.6 1012.0 (loss of ) 690.4 (, B₃) 533.3 (Hex-Hex-HexNAc(cross-ring), ^3,5A₃)			D only
1141.6 1012.0 (loss of ) 690.4 (, B₃) 472.3 (, B/Y)			B,C,D
1141.6 1012.0 (loss of ) 690.4 (, B₃) 463.1 (, C₂)			D only
1141.6 1012.0 (loss of ) 690.4 (, B₃) 445.3 (, B₂)			D only

Table 4. MSn Pathways Topologies for the Ion m/z 1141.6 (Hex5HexNAc4deoxyhexose1) from a Humanized IgG Sample.

Table 4. MSⁿ Pathways Topologies for the Ion m/z 1141.6 (Hex₅HexNAc₄deoxyhexose₁) from a Humanized IgG Sample.